Most Read
Most Commented
mk-logo
News
WHO pauses hydroxychloroquine trial over safety concerns

CORONAVIRUS | The World Health Organization has suspended testing the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns, WHO director-general Tedros Adhanom Ghebreyesus said on Monday.

The World Health Organization said on Monday that it has suspended its trial of the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns.

Unlocking Article
Unlocking Article
View Comments
ADS